• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

问题陈述和方案评估(PFOA)将技术治理和环境风险评估联系起来:纳米技术和基因工程生物体问题分析的方法。

Problem formulation and option assessment (PFOA) linking governance and environmental risk assessment for technologies: a methodology for problem analysis of nanotechnologies and genetically engineered organisms.

机构信息

Department of Forest Resources, University of Minnesota, USA.

出版信息

J Law Med Ethics. 2009 Winter;37(4):732-48. doi: 10.1111/j.1748-720X.2009.00444.x.

DOI:10.1111/j.1748-720X.2009.00444.x
PMID:20122113
Abstract

Societal evaluation of new technologies, specifically nanotechnology and genetically engineered organisms (GEOs), challenges current practices of governance and science. Employing environmental risk assessment (ERA) for governance and oversight assumes we have a reasonable ability to understand consequences and predict adverse effects. However, traditional ERA has come under considerable criticism for its many shortcomings and current governance institutions have demonstrated limitations in transparency, public input, and capacity. Problem Formulation and Options Assessment (PFOA) is a methodology founded on three key concepts in risk assessment (science-based consideration, deliberation, and multi-criteria analysis) and three in governance (participation, transparency, and accountability). Developed through a series of international workshops, the PFOA process emphasizes engagement with stakeholders in iterative stages, from identification of the problem(s) through comparison of multiple technology solutions that could be used in the future with their relative benefits, harms, and risk. It provides "upstream public engagement" in a deliberation informed by science that identifies values for improved decision making.

摘要

对新技术(特别是纳米技术和基因工程生物)的社会评估对当前的治理和科学实践提出了挑战。将环境风险评估(ERA)用于治理和监督假设我们有合理的能力来理解后果并预测不利影响。然而,传统的 ERA 因其许多缺点而受到相当多的批评,而且当前的治理机构在透明度、公众投入和能力方面表现出了局限性。问题制定和方案评估(PFOA)是一种基于风险评估中的三个关键概念(基于科学的考虑、审议和多标准分析)和治理中的三个概念(参与、透明度和问责制)的方法。该方法是通过一系列国际研讨会开发的,强调在迭代阶段与利益相关者接触,从识别问题开始,然后对未来可能使用的多种技术解决方案进行比较,评估它们的相对收益、危害和风险。它提供了一种在科学信息基础上进行的“上游公众参与”,确定了改进决策的价值观。

相似文献

1
Problem formulation and option assessment (PFOA) linking governance and environmental risk assessment for technologies: a methodology for problem analysis of nanotechnologies and genetically engineered organisms.问题陈述和方案评估(PFOA)将技术治理和环境风险评估联系起来:纳米技术和基因工程生物体问题分析的方法。
J Law Med Ethics. 2009 Winter;37(4):732-48. doi: 10.1111/j.1748-720X.2009.00444.x.
2
Evaluating oversight systems for emerging technologies: a case study of genetically engineered organisms.评估新兴技术的监督系统:以基因工程生物体为例。
J Law Med Ethics. 2009 Winter;37(4):546-86. doi: 10.1111/j.1748-720X.2009.00431.x.
3
Commentary: Emerging technologies oversight: research, regulation, and commercialization.述评:新兴技术监督:研究、监管和商业化。
J Law Med Ethics. 2009 Winter;37(4):587-93. doi: 10.1111/j.1748-720X.2009.00432.x.
4
Commentary: Is it possible to determine the extent to which informational asymmetries and prejudice bias responses?述评:是否有可能确定信息不对称和偏见反应的程度?
J Law Med Ethics. 2009 Winter;37(4):594-7. doi: 10.1111/j.1748-720X.2009.00433.x.
5
Developing U.S. oversight strategies for nanobiotechnology: learning from past oversight experiences.制定美国纳米生物技术监督战略:从过去的监督经验中学习。
J Law Med Ethics. 2009 Winter;37(4):688-705. doi: 10.1111/j.1748-720X.2009.00441.x.
6
Science, ethics, and the "problems" of governing nanotechnologies.科学、伦理与纳米技术治理的“问题”。
J Law Med Ethics. 2009 Winter;37(4):749-58. doi: 10.1111/j.1748-720X.2009.00445.x.
7
Governance of nanotechnology and nanomaterials: principles, regulation, and renegotiating the social contract.纳米技术和纳米材料的治理:原则、监管和重新协商社会契约。
J Law Med Ethics. 2009 Winter;37(4):706-23. doi: 10.1111/j.1748-720X.2009.00442.x.
8
Risk communication for nanobiotechnology: to whom, about what, and why?纳米生物技术风险沟通:对谁、关于什么以及为什么?
J Law Med Ethics. 2009 Winter;37(4):759-69. doi: 10.1111/j.1748-720X.2009.00446.x.
9
Demand for command: responding to technological risks and scientific uncertainties.指令需求:应对技术风险与科学不确定性。
Med Law Rev. 2013 Winter;21(1):11-38. doi: 10.1093/medlaw/fws042. Epub 2013 Jan 17.
10
How to keep out what we don't want: an assessment of 'Sozialverträglichkeit' under the Austrian Genetic Engineering Act.如何排除我们不想要的东西:对奥地利《基因工程法》下“社会兼容性”的评估
Public Underst Sci. 1997 Oct;6(4):301-27. doi: 10.1088/0963-6625/6/4/002.

引用本文的文献

1
Adequacy and sufficiency evaluation of existing EFSA guidelines for the molecular characterisation, environmental risk assessment and post-market environmental monitoring of genetically modified insects containing engineered gene drives.对欧洲食品安全局(EFSA)现有指南的充分性和充足性评估,这些指南涉及含有工程基因驱动的转基因昆虫的分子特征描述、环境风险评估和上市后环境监测。
EFSA J. 2020 Nov 12;18(11):e06297. doi: 10.2903/j.efsa.2020.6297. eCollection 2020 Nov.
2
Towards inclusive social appraisal: risk, participation and democracy in governance of synthetic biology.迈向包容性社会评估:合成生物学治理中的风险、参与和民主
BMC Proc. 2018 Jul 19;12(Suppl 8):15. doi: 10.1186/s12919-018-0111-3. eCollection 2018.
3
Is it only the regulatory status? Broadening the debate on cisgenic plants.
仅仅是监管地位的问题吗?拓展关于顺基因植物的辩论。
Environ Sci Eur. 2017;29(1):22. doi: 10.1186/s12302-017-0120-2. Epub 2017 Jun 26.